Timber Pharmaceuticals TMBR Stock
Timber Pharmaceuticals Price Chart
Timber Pharmaceuticals TMBR Financial and Trading Overview
| Timber Pharmaceuticals stock price | 0.34 USD |
| Previous Close | 1.85 USD |
| Open | 1.95 USD |
| Bid | 1.8 USD x 1400 |
| Ask | 1.97 USD x 1100 |
| Day's Range | 1.84 - 1.93 USD |
| 52 Week Range | 1.2 - 17 USD |
| Volume | 51K USD |
| Avg. Volume | 315.31K USD |
| Market Cap | 5.66M USD |
| Beta (5Y Monthly) | -0.783731 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11 USD |
TMBR Valuation Measures
| Enterprise Value | 1.08M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1481482 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 4.266055 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.054 |
Trading Information
Timber Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.783731 |
| 52-Week Change | -86.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17 USD |
| 52 Week Low | 1.2 USD |
| 50-Day Moving Average | 1.55 USD |
| 200-Day Moving Average | 2.54 USD |
TMBR Share Statistics
| Avg. Volume (3 month) | 315.31K USD |
| Avg. Daily Volume (10-Days) | 1.74M USD |
| Shares Outstanding | 3.04M |
| Float | 2.98M |
| Short Ratio | 1.03 |
| % Held by Insiders | 0.72% |
| % Held by Institutions | 2.04% |
| Shares Short | 23.99K |
| Short % of Float | 0.80% |
| Short % of Shares Outstanding | 0.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -119.30% |
| Return on Equity (ttm) | -343.24% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -20093060 USD |
| Net Income Avi to Common (ttm) | -20367308 USD |
| Diluted EPS (ttm) | -7.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.18M USD |
| Total Cash Per Share (mrq) | 1.7 USD |
| Total Debt (mrq) | 625.43K USD |
| Total Debt/Equity (mrq) | 47.72 USD |
| Current Ratio (mrq) | 1.177 |
| Book Value Per Share (mrq) | 0.436 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16813156 USD |
| Levered Free Cash Flow (ttm) | -8780136 USD |
Profile of Timber Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Warren |
| Address | 3 Mountain View Road |
| ZIP | 07059 |
| Phone | 973 314 9577 |
| Website | https://www.timberpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. It is also involved in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. The company was founded in 2019 and is headquartered in Warren, New Jersey.
Q&A For Timber Pharmaceuticals Stock
What is a current TMBR stock price?
Timber Pharmaceuticals TMBR stock price today per share is 0.34 USD.
How to purchase Timber Pharmaceuticals stock?
You can buy TMBR shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Timber Pharmaceuticals?
The stock symbol or ticker of Timber Pharmaceuticals is TMBR.
Which industry does the Timber Pharmaceuticals company belong to?
The Timber Pharmaceuticals industry is Biotechnology.
How many shares does Timber Pharmaceuticals have in circulation?
The max supply of Timber Pharmaceuticals shares is 3.43M.
What is Timber Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Timber Pharmaceuticals PE Ratio is 0.00000000 now.
What was Timber Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Timber Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Timber Pharmaceuticals company belong to?
The Timber Pharmaceuticals sector is Healthcare.